Nitric oxide synthase inhibitors attenuate acute and chronic morphine withdrawal response in the rat locus coeruleus: An in vivo voltammetric study

Brain Research

Volumn 739, Issue 1-2, 1996, Pages 182-191

  Hall, Sean ^a   Milne, Brian ^a   Jhamandas, Khem ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

locus coeruleus; morphine; naloxone; nitric oxide synthase inhibitor; voltammetry; withdrawal syndrome

Indexed keywords

CATECHOLAMINE; MORPHINE; N(G) NITROARGININE; N(G) NITROARGININE METHYL ESTER; NALOXONE; NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR; CONTROLLED STUDY; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LOCUS CERULEUS; MALE; MORPHINE ADDICTION; NONHUMAN; POTENTIOMETRY; PRIORITY JOURNAL; RAT; WITHDRAWAL SYNDROME;

ANALYSIS OF VARIANCE; ANIMALS; ELECTROCHEMISTRY; ENZYME INHIBITORS; INJECTIONS, INTRAVENTRICULAR; LOCUS COERULEUS; MALE; MORPHINE; NALOXONE; NARCOTIC ANTAGONISTS; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; RATS; RATS, SPRAGUE-DAWLEY; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 0030580387     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(96)00823-2     Document Type: Article

References (73)

1. G-nitro-L-arginine methyl ester, Life Sci., 52 (1993) 245-249.
2. [2] Adams, R.E. and Wooten, G.F., Dependence and withdrawal following intracerebroventricular and systemic morphine administration: functional anatomy and behavior, Brain Res., 518 (1990) 6-10.
3. [3] Aghajanian, G.K., Tolerance of locus coeruleus to morphine and supression of withdrawal response by clonidine, Nature, 276 (1978) 186-188.
4. [4] Aghajanian, G.K., Kogan, J.H. and Moghaddam, B., Opiate withdrawal increase glutamate and aspartate efflux in the locus coeruleus: an in vivo microdialysis study, Brain Res., 636 (1994) 126-130.
5. [5] Akaoka, H. and Aston-Jones, G., Opiate withdrawal-induced hyperactivity of locus coeruleus neurons is substantially mediated by augmented excitatory amino acid input, J. Neurosci., 11 (1991) 3830-3839.
6. [6] Andrade, R., Vander Maelen, C.P. and Aghajanian, G.K., Morphine tolerance and dependence in the locus coeruleus: single cell studies in brain slices, Eur. J. Pharmacol., 91 (1983) 161-169.
7. [7] Aston-Jones, G., Ennis, M., Pieribone, V.A., Nickell, W.T. and Shipley, M.T., The brain nuclues locus coeruleus: restricted afferent control of a broad efferent network, Science, 234 (1986) 734-737.
8. [8] Baraban, S.C., Stornetta, R.L. and Guyenet, P.G., Effects of morphine withdrawal on adrenergic neurons of the rat rostral ventrolateral medulla, Brain Res., 676 (1995) 245-257.
9. [9] Blaise, G., To, Q., Parent, M., Lagarde, B., Asenjo, F. and Sauve, R., Does halothane interfere with the release, action, or stability of endothelium-derived relaxing factor/nitric oxide, Anesthesiology, 80 (1994) 417-426.
10. [10] Blasig, J., Herz, A., Reinhold, H.K. and Zieglgansberger, S., Development of physical dependence on morphine in respect to time and dosage and quantification of the precipitated withdrawal syndrome in rats, Psychopharmacology, 33 (1973) 19-38.
11. [11] Bredt, D.S. and Synder, S.H., Nitric oxide, a novel neuronal messenger, Neuron, 8 (1992) 3-11.
12. [12] Buda, M., De Simoni, G., Gonon, F. and Pujol, J.F., Catecholamine metabolism in the rat locus coerulues as studied by in vivo differential pulse voltammetry. I. Nature and origin of contributors to the oxidation current at +0.1 V., Brain Res., 273 (1983) 197-206.
13. [13] Buda, M. and Gonon, F., Study of brain noradrenergic neurons by use of in vivo voltammetry. In: J.B. Justice (Ed.), Voltammetry in the Neurosciences, Humana Press, Clifton, NJ, (1987) 239-272.
14. [14] Cameron, A.A., Khan, I.A., Westlund, K.N. and Willis, W.D., The efferent projections of the periaqueductal grey in the rat: a phaseolus vulgaris-Leucoagglutinin study. II. descending projections, J. Comp. Neurol., 351 (1995) 585-601.
15. [15] Cappendijk, S.L.T., Duval, S.Y., de Vries, R. and Dzoljic, M.R., Comparative study of normotensive and hypertensive nitric oxide synthase inhibitors on morphine withdrawal syndrome in rats, Neurosci. Lett., 183 (1995) 67-70
16. [16] Chieng, B., Keay, K.A. and Christie, M.J., Increased fos-like immunoreactivity in the periaqueductal grey of anaesthetized rats during opiate withdrawal, Neurosci. Lett., 183 (1995) 79-82.
17. [17] Connop, B.P., Boegman, R.J., Jhamandas, K. and Beninger, R.J., Excitotoxic action of NMDA agonists on nigrostriatal dopaminergic neurons: modulation by inhibition of nitric oxide synthesis, Brain Res., 676 (1995) 124-132.
18. [18] Curet, O., Dennis, T. and Scatton, B., The formation of deaminated metabolites of dopamine in the locus coeruleus depends upon noradrenergic activity, Brain Res., 335 (1985) 297-301.
19. [19] D'Amour, F.E. and Smith, D.L., A method for determining loss of pain sensation, J. Pharmacol. Exp. Ther., 72 (1941) 74-79.
20. [20] Dahlstrom, A. and Fuxe, L., Evidence for the existence of monoamine-containing neurons in the central nervous system. I. Demonstration of monoamines in the cell bodies of brain stem neurons, Acta Physiol. Scand., 62 (1964) 1-55.
21. [21] Duggan, S., Hong, M., Milne, B. and Jhamandas, K., The role of excitatory amino acids inn the expression of precipiteated acute and chronic clonidine withdrawal: an in vivo voltammetric study in the rat locus coeruleus, Brain Res., 665 (1994) 253-261.
22. [22] Duman, R.S., Tallman, J.F. and Nestler, E.J., Acute and chronic opiate-regulation of adenylate cyclase in brain: specific effects in locus coeruleus, J. Pharmacol. Exp. Ther., 246 (1988) 1033-1039.
23. [23] Ennis, M. and Aston-Jones, G., Activation of locus coeruleus from nucleus paragigantocellularis: a new excitatory amino acid pathway in the brain, J. Neurosci., 8 (1988) 3644-3657.
24. [24] Ennis, M., Aston-Jones, G. and Shiekhattar, R., Activation of locus coeruleus neurons by nucleus paragigantocellularis or noxious sensory stimulation is mediated by intracoerular excitatory amino acid neurotransmission, Brain Res., 598 (1992) 185-195.
25. [25] Field, K.J., White, W.J. and Lang, C.M., Anasthetic effects of chloral hydrate, pentobarbitone and urethane in adult male rats, Lab. Anim., 27 (1993) 258-269.
26. [26] Foote, S.L., Bloom, F.E. and Aston-Jones, G., Nucleus locus coeruleus: new evidence of anatomical and physiological specificity, Physiol. Rev., 63 (1983) 844-914.
27. [27] Furuyama, T., Inagaki, S. and Takagi, H., Localizations of α1 and β 1 subunits of soluble guanylate cyclase in the rat brain, Mol. Brain Res., 20 (1993) 335-344.
28. [28] Garthwaite, J., Glutamate, nitric oxide and cell-cell signalling in the nervous system, Trends Neurosci., 14 (1991) 60-67.
29. [29] Garthwaite, J., Charles, S.L. and Chess-Williams, R., Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain, Nature, 336 (1988) 385-388.
30. [30] Gillon, J.Y., Quintin, L., Ghignone, M. and Pujol, J.F., Clonidine modulates the ventrolateral medullary catechol metabolic hyperactivity induced by hypotension, Brain Res., 418 (1987) 157-163.
31. [31] Gonon, F., Naverre, F. and Buda, M., In vivo monitoring of dopamine release in the rat brain with differential normal pulse voltammetry, Anal. Chem., 56 (1984) 573-575.
32. [32] Hong, M., Milne, B. and Jhamandas, K., Evidence for the involvement of excitatory amino acid pathways in the development of precipitated withdrawal from acute and chronic morphine: an in vivo voltammetric study in the rat locus coeruleus, Brain Res., 623 (1993) 131-141.
33. [33] Hong, M., Milne, B., Loomis, C.W. and Jhamandas, K., In vivo catechol activity in the rat locus coeruleus following different nociceptive stimuli and naloxone. Can. J. Physiol. Pharmacol., 70 (1992) 1082-1089.
34. [34] Horn, T., Smith, P.M., McLaughlin, B.E., Bauce, L., Marks, G.S., Pittman, Q.L. and Ferguson, A.V., Nitric oxide actions in paraventricular nucleus: cardiovascular and neurochemical implications, Am. J. Physiol., 266 (1994) R306-R313.
35. [35] Iadecola, C., Faris, P.L., Hartman, B.K. and Xu, X., Localization of NADPH diaphorase in neurons of the rostral ventral medulla: possible role of nitric oxide in central autonomic regulation and oxygen chemoreception, Brain Res., 603 (1993) 173-179.
36. [36] Johns, R.A., Moscicki, J.C. and Difazio, C.A., Nitric oxide synthase inhibitor dose-dependently and reversibly reduces the threshold for halothane anesthesia, Anesthesiology, 77 (1992) 779-784.
37. [37] Kant, G.J., Muller, T.W., Lenox, R.H. and Meyerhoff, J.L., In vivo effects of pentobarbital and halothane anesthesia on levels of andenosine 3′,5′-monophosphate and guanosine 3′,5′-monophosphate in rat brain regions and pituitary, Biochem. Pharmacol., 29 (1980) 1891-1896.
38. [38] Kawagoe, K.T., Zimmerman, J.B. and Whijtman, R.M., Principles of voltammetry and microelectrode slates, J. Neurosci. Methods, 48 (1993) 225-240.
39. [39] Kimes, A.S., Vaupel, D.B. and London, E.D., Attenuation of some signs of opioid withdrawal by inhibitors of nitric oxide synthase, Psychopharmacology, 112 (1993) 521-524.
40. [40] Kogan, J.H., Nestler, E.J. and Aghajanian, G.K., Elevated basal firing rates and enhanced responses to 8-Br-cAMP in locus coeruleus neurons in brain slices from opiate dependent rats, Eur. J. Pharmacol., 211 (1992) 47-53.
41. [41] Loomis, C.W., Milne, B. and Cervenko, F.W., Determination of cross-tolerance in rat spinal cord using intrathecal infusion via sequential mini-osmotic pumps, Pharmacol. Biochem. Behav., 29 (1987) 131-139.
42. [42] Luppi, P.-H., Aston-Jones, G., Akaoka, H., Chouvet, G. and Jouvet, M., Afferent projections to the rat locus coeruleus demonstrated by retrograde and anterograde tracing with cholera-toxin B subunit and phaseolus vulgaris leucoagglutinin, Neuroscience, 65 (1995) 119-160.
43. [43] Maldonado, R. and Koob, G.F., Destruction of the locus coeruleus decrease physical signs of opiate withdrawal, Brain Res., 605 (1993) 128-138.
44. [44] Maldonado, R., Stinus, L., Gold, L.H. and Koob, G.F., Role of different brain structures in the expression of the physical morphine withdrawal syndrome, J. Pharm. Exp. Ther., 261 (1992) 669-677.
45. [45] Mansour, A., Fox, C.A., Akil, H. and Watson, S.J., Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications, Trends Neurosci., 18 (1995) 22-29.
46. [46] Matsuoka, I., Giuli, G., Poyard, M., Stengel, D., Parma, J., Guellane, G. and Hanoune, J., Localization of adenylyl and guanylyl cyclase in the rat brain by in situ hybridization: comparision with calmodulin mRNA distribution, J. Neurosci., 12 (1992) 3350-3360.
47. [47] Milne, B., Quintin, L., Gillon, J.Y. and Pujol, J.F., Fentanyl decreases catecholamine metabolism measured by in vivo voltammetry in the rat locus coeruleus, Can. J. Physiol. Pharmacol., 67 (1989) 532-536.
48. [48] Montague, P.R., Gancayco, C.D., Winn, M.J., Marchase, R.B. and Freidlander, M.J., Role of NO production in NMDA receptor-mediated neurotransmitter release in cerebral cortex, Science, 263 (1994) 973-977.
49. [49] Onstott, D., Mayer, B. and Beitz, A.J., Nitric oxide synthase immunoreactive neurons anatomically define a longitudinal dorsalateral column within the midbrain periaqueductal grey of the rat: analysis using laser confocal microscopy, Brain Res., 610 (1993) 317-324.
50. [50] Ortemann, C., Robert, F., Renaud, B. and Lambás-Señas, L., In vivo microdialysis study of the extracellular 3,4-dihydroxyphenylacetic acid in the rat locus coeruleus; topographical and pharmacological aspects, J. Neurochem., 61 (1993) 594-601.
51. [51] Pieribone, V.A., Aston-Jones, G. and Bohn, M.C., Adrenergic and non-adrenergic neurons in the C1 and C3 areas project to locus coeruleus: a flourescent double labelling study, Neurosci. Lett., 85 (1988) 297-303.
52. [52] Pineda, J., Kogan, J.H. and Aghajanian, G.K., Nitric oxide and carbon monoxide activate locus coeruleus neurons through a cGMP-dependent protein kinase: involvement of a nonselective cationic channel, J. Neurosci., 16 (1996) 1389-1399.
53. [53] Quintin, L., Hilaire, G. and Pujol, F., Variations in DOPAC concentration are correlated to single cell firing changes in the rat locus coeruleus, Neuroscience, 18 (1986) 889-899.
54. [54] Rasmussen, K., Afferrent effects on locus coeruleus in opiate withdrawal, Prog. Brain Res., 88 (1991) 207-216.
55. [55] Rasmussen, K. and Aghajanian, G.K., Withdrawal-induced activation of locus coeruleus neurons in opiate-dependent rats: attenuation by lesions of the nucleus paragigantocellularis, Brain Res., 505 (1989) 346-350.
56. [56] Rasmussen, K., Beitner-Johnson, D.B., Krystal, J.H., Aghajanian, G.K. and Nestler, E.J., Opiate withdrawal and the rat locus coeruleus: behavioral, electrophysiological, and biochemical correlates, J. Neurosci., 10 (1990) 2308-2317.
57. [57] Rasmussen, K., Fuller, R.W., Stockton, M.E., Perry, K.W., Swinford, R.M. and Ornstein, P.L., NMDA receptor antagonists suppress behaviors but not norepinepherine turnover or locus coeruleus unit activity induced by opiate withdrawal, Eur. J Pharmacol., 197 (1991) 9-16.
58. [58] Rasmussen, K., Krystal, J.H. and Aghajanian, G.K., Excitatiory amino acids and morphine withdrawal: differential effects of central and peripheral kynurenic acid administration, Psychopharmacology, 105 (1991) 508-512.
59. [59] Redmond, D.E., Huang, Y.J., Synder, D.R. and Mass, J.W., Behavioral effects of stimulation of the nucleus locus coeruleus in the stump-tailed monkey (Macaca arctoides), Brain Res., 116 (1976) 502-510.
60. [60] Reisine, T., Opiate receptors, Neuropharmacology, 34 (1995) 463-472.
61. G-nitro-L-arginine (L-NA) and its methyl ester (L-NAME), Neuropharmacology, 34 (1995) 639-649.
62. [62] Salter, M., Duffy, C. and Hazelwood, R., Determination of brain nitric oxide synthase inhibition in vivo: ex vivo assays of nitric oxide synthase can give incorrect results, Neuropharmacology, 43 (1995) 327-334.
63. [63] Singewald, N. and Philippu, A., Catecholamine release in locus coeruleus is modified by experimentally induced changes in haemodynamics, Naunyn-Schmiedebergs Arch. Pharmacol., 347 (1993) 21-27.
64. [64] Singewald, N., Zhou, G. and Schneider, C., Release of excitatory and inhibitory amino acids from the locus coeruleus of conscious rats by cardiovascular stimuli and various methods of acute stress, Brain Res., 704 (1995) 42-50.
65. [65] Stornetta, R.L., Norton, F.E. and Guyenet, P.G., Autonomic areas of rat brain exhibit increased fos-like immunoreactivity during opiate withdrawal in rats, Brain Res., 624 (1993) 19-28.
66. [66] Taylor, J.R., Elsworth, J.D., Garcia, E.J., Grant, S.J., Roth, R.H. and Redmond, D.E., Clonidine infusion into the locus coeruleus attenuates behavioural and neurochemical changes associated with naloxone-precipitated withdrawal, Psychoparmacology, 96 (1988) 12-134.
67. [67] Trujillo, K.A. and Akil, H., Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801, Science, 251 (1991) 85-87.
68. [68] Tseng, L.F., Loh, H.H. and Wei, E.T., Effects of clonidine on morphine withdrawal signs in the rat, Eur. J. Pharmacol, 30 (1975) 93-99.
69. [69] Tung, C.S., Grenhoff, J. and Svensson, T.H., Morphine withdrawal responses of rat locus coeruleus neurons are blocked by an excitatory amino-acid antagonist, Acta Physiol. Scand., 138 (1990) 581-582.
70. [70] Valentino, R.J. and Wehby, R.G., Morphine effects on locus coeruleus neurons are dependent on the state of arousal and availability of external stimuli: studies in anesthitized and unanesthitized rats, J. Pharmacol Exp. Ther., 244 (1988) 1178-1186.
71. [71] Wang, L., Milne, B. and Jhamandas, K., Involvement of excitatory amino acid pathways in the expression of precipitated opioid withdrawal in the rostral ventrolateral medulla: an in vivo voltammetric study, Brain Res., 697 (1995) 130-142.
72. [72] Xu, Z, Pieribone, V.A., Zhang, X., Grillner, S. and Hökfelt, T., A functional role for nitric oxide in the locus coeruleus: immunohistochemical and electrophysiological studies, Exp. Brain Res., 98 (1994) 75-83.
73. [73] Zhang, T., Feng, Y., Rockhold, R. and Ho, I., Naloxone-precipitated morphine withdrawal increases pontine glutamate levels in the rat, Life Sci., 55 (1994) 25-31.